Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy by 媛뺤떊�슧 et al.
Introduction
The prevalence of obesity has been gradually increasing 
worldwide during the past few decades. Obese persons 
are more likely to have hypertension, dyslipidaemia, 
and diabetes mellitus (DM) than non-obese persons, 
which are important causes of cardiovascular and cere-
brovascular diseases. Accordingly, mortality rates are 
higher in this population [1]. It is also highly associated 
with the development of chronic kidney disease (CKD), 
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Background: Many epidemiologic studies have reported on the controversial concept of the obesity paradox. The 
presence of acute kidney injury (AKI) can accelerate energy-consuming processes, particularly in patients requiring 
continuous renal replacement therapy (CRRT). Thus, we aimed to investigate whether obesity can provide a survival 
benefit in this highly catabolic condition.
Methods: We conducted an observational study in 212 patients who had undergone CRRT owing to various causes 
of AKI between 2010 and 2014. The study end point was defined as death that occurred within 30 days after the 
initiation of CRRT.
Results: Patients were categorized into three groups according to tertiles of body mass index (BMI). During 30 days 
after the initiation of CRRT, 39 patients (57.4%) in the highest tertile died, as compared with 58 patients (78.4%) in 
the lowest tertile (P = 0.02). In a multivariable analysis adjusted for cofounding factors, the highest tertile of BMI was 
significantly associated with a decreased risk of death (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.37-
0.87; P = 0.01). This significant association remained unaltered for 60-day (HR, 0.64; 95% CI, 0.43-0.94; P = 0.03) 
and 90-day mortality (HR, 0.66; 95% CI, 0.44-0.97; P = 0.03). 
Conclusion: This study showed that a higher BMI confer a survival benefit over a lower BMI in AKI patients undergoing 
CRRT.
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microalbuminuria, and overt proteinuria [2]. With such 
increasing prevalence, many critically ill patients who re-
quire treatment in the intensive care unit (ICU) also have 
obesity. A previous meta-analysis from the United States 
showed that approximately 30% of ICU patients had a 
body mass index (BMI) of ≥ 30 kg/m2, and these patients 
had prolonged durations of mechanical ventilation and 
lengths of ICU stay [3]. 
Acute kidney injury (AKI) occurs in many hospitalized 
and ICU patients, and is significantly associated with ad-
verse outcomes such as high mortality, increased length 
of hospital stay, and progression to CKD [4]. Given the 
high burden of comorbidities accompanying obesity, 
it can be inferred that obese patients are prone to the 
development of AKI and thus experience more serious 
complications than non-obese patients with critical 
conditions. However, this assumption has not yet been 
clearly proven, and there has been much controversy on 
the relationship between AKI, obesity, and mortality. In 
fact, several studies have shown that obesity is associated 
with a high incidence and severity of AKI [5-7], as well as 
increased mortality in ICU patients [6]. In contrast, an in-
verse or null relationship between obesity and mortality 
has also been reported in other studies [5,8-12]. 
This phenomenon, called the ‘obesity paradox’, has 
been observed in patients with chronic diseases . In par-
ticular, in CKD patients, a higher BMI is associated with 
a lower risk of all-cause mortality [13], than a normal or 
lower BMI. Furthermore, recent evidence has shown that 
obese patients undergoing ICU and ventilator therapy 
have a survival benefit over non-obese patients [5]. Al-
though the physiologic mechanism is not yet established, 
fat tissue as an energy reservoir has been suggested to 
explain this beneficial effect of obesity [14]. Of note, 
sepsis is characterized by increased protein catabolism 
and high energy consumption. It can be presumed that 
this process can be more deteriorated particularly when 
complicated by AKI in patients requiring renal replace-
ment therapy. Therefore, we aimed to delineate the re-
lationship between obesity and mortality in critically ill 
patients with AKI who were treated with continuous renal 
replacement therapy (CRRT).
Methods
Patients
We conducted an observational study in 212 adult pa-
tients who were treated with CRRT in the ICU of our insti-
tution between January 2010 and December 2014. A total 
of 573 patients were initially assessed for study eligibility. 
Patients were excluded if they were ≤ 18 or ≥ 75 years old, 
had end-stage renal disease (ESRD) on dialysis, or had 
stage 4 malignancy. Patients who had no BMI data were 
also excluded (Fig. 1). The study was approved by the In-
stitutional Review Board of Yonsei University Severance 
Hospital (4-2010-0440). Since current study was a retro-
spective observational study and the study subjected de-
identified, the IRB waived the need for written consent 
from the patients.
Data collection
Demographic factors and comorbid conditions were 
obtained from electronic medical records. The Charlson 
comorbidity index (CCI) was used to evaluate the severity 
of the patients’ comorbidities [15], and BMI was calculat-
ed by using the height and weight data obtained on ICU 
admission (weight [kg]/height [m2]). The causes of AKI 
were classified into five categories: (i) sepsis, (ii) neph-
rotoxin, (iii) hypovolemic ischemia, (iv) surgery, and (v) 
others. Blood samples were collected immediately after 
ICU admission. The measured laboratory data included 
white blood cell (WBC) count, haemoglobin, haemato-
crit, platelet, prothrombin time, partial thromboplastin 
time, cholesterol, albumin, blood urea nitrogen, and cre-
atinine. The estimated glomerular filtration rate (eGFR) 
573 patients screened
250 patients for AKI cohort
212 patients enrolled
Excluded patients with no
record of BMI ( = 38)n
Excluded
- Age < 18 yr or > 75 yr ( = 138)
- ESRD on dialysis ( = 14)
- Stage 4 malignancy ( = 171)
n
n
n
Figure 1. Flowchart of participants in the cohort. AKI, acute kid-
ney injury; BMI, body mass index; ESRD, end stage renal disease.
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was determined by using the Modification of Diet in Re-
nal Disease equation [16]. The average vital signs, PaO2, 
FiO2, and Glasgow coma scale score in the first 24 hours 
of ICU admission were collected to calculate the sepsis-
related organ failure assessment (SOFA) score. 
Outcomes
The primary outcome was death from any cause that 
occurred at 30 days after CRRT initiation. Secondary out-
comes included death from any cause occurred at 60 and 
90 days after CRRT initiation, and weaning from CRRT 
due to renal recovery. 
Statistical analyses
Continuous variables were expressed as mean ± stan-
dard deviation, and compared with t-test and one-way 
ANOVA. The normality of the distribution of parameters 
was analysed by using the Kolmogorov-Smirnov test. If 
data did not show a normal distribution, these were pre-
sented as median and interquartile range and compared 
Table 1. Baseline characteristics of patients according to BMI tertiles
Characteristic
BMI (kg/m2) tertiles
P
Tertile 1 (13.5-21.8) Tertile 2 (21.9-25.4) Tertile 3 (25.5-37.1)
Patient (n) 74 70 68
Age (yr) 61.8 ± 13.2 64.0 ± 11.8 60.5 ± 14.1 0.29
Sex (female) 23 (31.1) 26 (37.1) 25 (36.8) 0.69
Diabetes mellitus 16 (21.9) 16 (22.9) 26 (38.2) 0.06
Hypertension 31 (41.9) 35 (50.0) 34 (50.0) 0.53
Myocardiac infarction 1 (1.4) 3 (4.3) 0 (0.0) 0.17
Congestive heart failure 7 (9.5) 4 (5.7) 7 (10.3) 0.59
Cerebrovascular attack 4 (5.6) 5 (7.1) 2 (2.9) 0.80
Peripheral vascular disease 1 (1.4) 2 (2.9) 0 (0.0) 0.36
COPD 2 (2.7) 4 (5.7) 6 (8.8) 0.29
Cancer 46 (62.2) 42 (60.9) 35 (51.5) 0.2
CCI score 2.9 ± 1.9 2.9 ± 2.1 3.0 ± 2.5 0.96
AKI cause 
   Sepsis
   Nephrotoxin 
   Ischemia
   Surgery
   Others
57 (77.0)
1 (1.4)
2 (2.7)
1 (1.4)
13 (17.6)
59 (84.3)
0 (0.0)
0 (0.0)
0 (0.0)
11 (15.7)
49 (72.1)
1 (1.5)
0 (0.0)
0 (0.0)
18 (26.5)
0.30
BMI (kg/m2) 19.4 ± 2.0 23.6 ± 1.1 28.6 ± 2.8 <0.001
MAP (mmHg) 79.8 ± 14.3 79.6 ± 15.8 77.4 ± 13.5 0.55
BUN (mg/dL) 54.2 ± 26.8 67.4 ± 29.0 66.0 ± 39.4 0.03
Creatinine (mg/dL) 2.5 ± 1.2 3.6 ± 2.2 3.2 ± 1.6 0.001
eGFR (mL/min/1.73m2) 32.8 ± 31.0 23.2 ± 18.1 22.5 ± 10.5 0.008
WBC (× 103/mm3) 13.8 ± 13.5 13.3 ± 11.2 13.7 ± 10.1 0.96
Hemoglobin (g/dL) 9.7 ± 1.8 9.3 ± 1.8 9.2 ± 2.2 0.24
Albumin (g/dL) 2.5 ± 0.6 2.4 ± 0.6 2.5 ± 0.5 0.33
Potassium (mmol/L) 4.4 ± 0.8 4.4 ± 1.0 4.5 ± 1.0 0.70
Mechanical ventilation 66 (89.2) 56 (80.0) 55 (80.9) 0.26
Vasopressor 57 (76.5) 57 (81.4) 58 (85.2) 0.42
SOFA 14.1 ± 3.0 14.1 ± 3.3 14.4 ± 3.0 0.87
Data are presented as number only, number (%), or mean ± standard deviation.  
AKI, acute kidney injury; BMI, body mass index; BUN, blood urea nitrogen; CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; 
eGFR, estimated glomerular filtration rate; MAP, mean arterial pressure; SOFA, sepsis-related organ failure assessment; WBC, white blood cell.
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by using the Mann-Whitney test or Kruskal-Wallis test. 
Categorical variables were expressed as percentages and 
compared with the chi-square test. Cumulative survival 
curves were derived using the Kaplan-Meier method, and 
differences between curves were analysed by log-rank 
test. To evaluate the relationship of BMI, covariables, and 
mortality, a Cox-proportional hazard model was used, 
and the results were presented as a hazard ratio (HR) 
and 95% confidence interval (CI). In addition, receiver 
operating characteristic (ROC) curve analysis was con-
ducted and the cut-off value of BMI for the outcome was 
derived by Youden index, which is the maximum vertical 
distance between ROC curve and chance line. Statistical 
significance was defined as P < 0.05. All analyses were 
conducted by using IBM SPSS Statistics, version 20.0 (IBM 
Co., Armonk, NY, USA) and R language (version 3.3.1; R 
Foundation for Statistical Computing, Vienna, Austria).
Results
Patient characteristics
The baseline characteristics of the patients and the 
CRRT prescription are presented in Tables 1 and 2, re-
spectively. We classified patients into tertiles according 
to BMI: Q1, 13.5-21.8 kg/m2; Q2, 21.9-25.4 kg/m2; and 
Q3, 25.5-37.1 kg/m2. The average BMI was 23.9 ± 4.3 kg/
m2. The mean age was 62.1 years, and 74 patients (34.9%) 
were women. The prevalence of hypertension, DM, and 
other comorbidities did not significantly differ between 
groups. The mean age-adjusted CCI score was 4.6 ± 2.6 
and was similar in the three groups. Sepsis was a pre-
dominant cause of AKI (77.8%), and occurred less fre-
quently in high tertiles; however, the difference did not 
reach statistical significance (P = 0.3). The mean eGFR at 
the time of starting CRRT was 26.3 ± 22.3 mL·min-1·1.73 
m-2, and the initial kidney function of lowest tertile was 
significantly higher than those of other two quartiles (P 
= 0.008). The average SOFA score was 14.2 ± 3.1, and the 
severity of illness was not significantly different between 
groups (P = 0.54). 
ICU and hospital stay durations and mortality rates 
according to BMI tertiles
The ICU and hospital stay durations, survival days, and 
30, 60 and 90-day mortality rates are presented in Table 2. 
The mean ICU and hospital stay was 6 (3-15) and 11 (3-
32) days, respectively. Patients with a higher BMI stayed 
longer in the ICU and hospital than those with a lower 
BMI; however, the differences did not reach statistical sig-
nificance. A total of 141 deaths (66.5%) occurred during 
30 days after CRRT initiation. Most patients died of sepsis 
and there was no difference in cause of death between 
groups (data not shown). Thiry-nine patients (57.4%) 
in the highest tertile died as compared with 58 patients 
(78.4%) in the lowest tertile (P = 0.02). The Kaplan-Meier 
curve of the 30-day shows that the cumulative survival 
of the highest BMI tertile group was significantly higher 
than those of the lowest BMI group (Fig. 2, P = 0.04). An 
additional 19 deaths occurred between 30 and 90 days. 
When we analysed the 90-day mortality rate, there were 
 Table 2. Length of stay, survival, and mortality according to body mass index tertiles
Variable
BMI tertiles
P
Tertile 1 Tertile 2 Tertile 3
ICU LOS (d) 5 (2-12.5) 5.5 (3-15.3) 9 (4-18) 0.17
Hospital LOS (d) 7.5 (2-20) 12 (3-34.25) 4 (14-34) 0.28
Mortality (d)
   30 58 (78.4) 44 (62.9) 39 (57.4) 0.02
   60 60 (81.1) 50 (71.4) 47 (69.1) 0.22
   90 60 (81.1) 51 (72.9) 49 (72.1) 0.38
Weaning from CRRT
   30 13 (17.6) 16 (22.9) 18 (26.5) 0.15
   60 9 (12.2) 14 (20.0) 14 (20.6) 0.83
   90 10 (13.5) 13 (18.6) 12 (17.6) 0.67
Data are expressed as median (interquartile range) or number (%). 
CRRT, continuous renal replacement therapy; ICU, intensive care unit; LOS, length of stay.
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49 deaths (72.1%) in the highest tertile as compared with 
60 deaths (81.1%) in the lowest tertile (P = 0.37). There 
were no differences of renal survival at all time points.
Relationship between BMI and mortality in multivariable- 
adjusted models
We further analysed the association between BMI and 
mortality by using multivariable-adjusted Cox models. To 
this end, we constructed four different models (Table 3). 
In model 1, in which sex, age-adjusted CCI score, septic 
AKI, and SOFA score were entered, the highest tertile of 
BMI was significantly associated with a decreased risk of 
death (HR, 0.58; 95% CI, 0.38-0.88; P = 0.01). In model 2, 
we additionally adjusted WBC and albumin as inflamma-
tory and nutritional markers, and found that the survival 
benefit of a high BMI persisted. Finally, in model 3, CRRT 
prescription was added to model 2. In this fully adjusted 
model, patients in the highest tertile had a significantly 
decreased risk of death compared with those in the low-
est tertile (HR, 0.57; 95% CI, 0.37-0.87; P = 0.01). When 
BMI was analysed as a continuous variable, a high BMI 
was still independently associated with a decreased risk 
of death (HR, 0.94 per 1 kg/m2 increase; 95% CI, 0.90-
0.99; P = 0.007). We further analysed the 60-day and 90-
day mortality in these patients, and obtained similar 
results. In subgroup analyses according to presence of 
sepsis and cancer, survival benefit of high BMI was seen 
in only patients with sepsis (Fig. 3). In addition, to evalu-
ate the cut-off value of BMI as a prognostic marker for 
outcome, ROC analysis was conducted. The area under 
 Table 3. Multivariable Cox regression analyses for mortality
Follow-up BMI tertiles
Model 1 Model 2 Model 3 Model 4
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
30-day Tertile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 0.94 (0.90-0.98) 0.01
Tertile 2 0.77 (0.52-1.16) 0.21 0.76 (0.51-1.16) 0.21 0.77 (0.51-1.15) 0.2
Tertile 3 0.58 (0.38-0.88) 0.01 0.58 (0.38-0.87) 0.01 0.57 (0.37-0.87) 0.01
60-day Tertile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 0.96 (0.92-0.99) 0.03
Tertile 2 0.87 (0.59-1.28) 0.48 0.85 (0.58-1.26) 0.43 0.85 (0.58-1.26) 0.43
Tertile 3 0.65 (0.44-0.95) 0.03 0.64 (0.43-0.94) 0.02 0.64 (0.43-0.94) 0.03
90-day Tertile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 0.96 (0.92-0.99) 0.03
Tertile 2 0.88 (0.60-1.29) 0.51 0.86 (0.59-1.27) 0.45 0.86 (0.58-1.27) 0.45
Tertile 3 0.67 (0.46-0.98) 0.03 0.66 (0.45-0.97) 0.03 0.66 (0.44-0.97) 0.03
Model 1, sex, age-adjusted CCI score, septic AKI, and SOFA score; Model 2, Model 1 + WBC and albumin; Model 3, Model 2 + CRRT prescription (total efflu-
ent volume); Model 4, Model 3 + BMI as a continuous variable. 
AKI, acute kidney injury; BMI, body mass index; CCI, Charlson comorbidity index; CI, confidence interval; CRRT, continuous renal replacement therapy; HR, 
hazard ratio; SOFA, sepsis-related organ failure assessment; WBC, white blood cell. 
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Figure 2. Kaplan-Meier curves of the 30-day mortality accord-
ing to body mass index tertiles.
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Figure 3. Hazard ratio for mortality according to presence of 
sepsis and cancer in fully adjusted model.
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ROC curve for BMI was 0.616, and optimal point of BMI 
derived from Youden index was 22.9 kg/m2.
Discussion
In this study, we showed that a higher BMI is associ-
ated inversely with mortality in AKI patients undergoing 
CRRT. By using different multivariable-adjusted models, 
we found a consistent survival advantage of a higher BMI 
over a lower BMI, even though patients with lower BMI 
had a superior initial kidney function than patients with 
higher BMI. With ROC curve, we showed that patients 
with BMI over 22.9 kg/m2, which is defined as overweight 
and obesity in Asian population by World Health Organi-
zation criteria, had low risk of mortality. Thus, our find-
ings are robust and can add evidence to the recently pre-
vailing concept of the ‘obesity paradox’, even in critically 
ill patients undergoing renal replacement therapy.
We particularly paid attention to AKI patients treated 
with CRRT. Critical ill patients are generally hypercata-
bolic, and have substantial energy expenditure in pro-
portion to the amount of stress [17]. In addition, patients 
with AKI have a high prevalence of malnutrition [18], and 
protein can be excessively degraded in uraemia caused 
by AKI [19]. Especially, loss of protein can be accelerated 
in AKI with CRRT, since protein and other nutritional 
elements are lost through CRRT [20]. Previous studies 
showed that 17% of centrally infused protein losses into 
CRRT effluent [21]. Accordingly, the American Society for 
Parenteral and Enteral Nutrition/Society of Critical Care 
Medicine Guidelines for the Provision and Assessment of 
Nutrition Support Therapy in the Adult Critically Ill Pa-
tient recommend that patients receiving hemodialysis or 
CRRT should receive increased protein, up to a maximum 
of 2.5 g/kg/day, and protein should not be restricted in 
patients with renal insufficiency [22]. In this regard, AKI 
patients on CRRT are more susceptible to a loss of energy 
reserve. To our knowledge, few studies have examined 
the relationship between obesity and adverse outcome 
in this exceptionally highly catabolic group. Consider-
ing this background, we sought to investigate whether 
obesity can exert protective effects against continuously 
energy-depleting conditions, and found that the obesity 
paradox indeed exists in these patients.
In general, obesity portends a high risk of developing 
adverse cardiovascular outcomes. However, contrary to 
this concept, many epidemiologic studies revealed an 
inverse relationship between obesity and mortality not 
only in chronic diseases [23,24] but also in the general 
population [25]. Recent evidence also indicates that this 
opposite relationship may hold true for acutely and seri-
ously ill patients under various conditions [5,7,10,26]. In 
fact, obesity has been considered a significant predictor 
of AKI. A recent observational cohort study also found 
that obese patients were at high risk of developing AKI 
than patients with normal BMI [6]. Conversely, obesity 
plays a different role in acutely ill patients, even in those 
having AKI. A previous meta-analyses involving a large 
number of ICU patients have suggested that patients with 
a higher BMI are more likely to survive than those with 
a lower BMI [3,9,11,27]. However, these studies require 
cautious interpretation because their meta-analyses were 
statistically heterogeneous and detailed adjustments 
were not made. Our study has the merit of applying three 
different multivariable models, taking all potential factors 
into account. Our database included demographic and 
laboratory data, comorbidity index, vital sign monitoring, 
scoring system for the severity of illness, and CRRT pre-
scription. Thus, we adjusted all these factors and found 
an inverse relationship between BMI and mortality, in 
agreement with previous studies [5,7-11].
A possible mechanistic link between obesity and a 
low death rate is largely presumptive. It is generally ac-
cepted that fat tissue can function as an energy reservoir; 
thus, obese patients can tolerate stressful and damaging 
conditions better than non-obese patients [28]. A recent 
study by Robinson et al [29] investigated the relationship 
among obesity, nutritional status, and mortality. In ac-
cordance with our study, they showed that high BMI was 
significantly associated with survival benefit in critical ill 
patients. Of note, they found malnutrition is less preva-
lent in obese patients than in underweight and normal 
patients, suggesting nutrition as a potential factor to 
explain survival advantage of obesity. Short-term protec-
tive cytokine profiles in obese patients [30,31] and other 
protective effects conferred by higher muscle mass [32] 
and fat tissue [33] have also been suggested as possible 
mechanisms responsible for this phenomenon. In aggre-
gates, it can be presumed that obesity provides substan-
tial energy resources and protective effects, and negates 
the harmful effects caused by inflammation, infection, 
and cardiovascular events. 
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Experimental evidence can also explain the favourable 
effects of obesity in AKI animal models. In a study by 
Sleeman et al [34], AKI was prevented by feeding a high-
fat diet to adult swine that underwent cardiopulmonary 
bypass. The authors suggested a ‘pre-conditioning’ effect 
of obesity against abrupt bursts of hyper-inflammation, 
which can attenuate pro-inflammatory redox signalling 
and help maintain renal vascular and tubular homeosta-
sis. Altered adipokine and cytokine profiles from adipose 
tissue can also play a role. Adiponectin and tumour ne-
crosis factor-α receptors are produced by adipose tissue 
and can exert protective effects by decreasing inflamma-
tion [31].
Several shortcomings should be discussed. First, al-
though we created multivariable models adjusted for 
many potential factors, this is an observational study 
with a relatively small sample size. Hence, unknown bias 
cannot be entirely excluded and our findings need to 
be interpreted with caution. Second, we used only BMI 
to evaluate obesity. BMI is easily measured and is the 
most widely used measure of obesity. However, it does 
not accurately reflect body composition [35]; thus, BMI 
is limited in assessing obesity. Other parameters such 
as abdominal diameter can be added to increase the 
diagnostic accuracy for obesity. Third, WBC and serum 
albumin were entered as inflammatory and nutritional 
markers in this study. Our database had laboratory data 
for CRP, a better marker of inflammation. However, > 
30% of the data were missing and thus cannot be used 
for analysis. In addition, serum albumin is a well-known 
nutritional marker [36]; however, it has a limited ability 
in reflecting nutritional status in critically ill patients be-
cause it is also a negative acute-phase reactant [37]. Nev-
ertheless, many studies have shown that high WBC and 
low serum albumin level are independent predictors of 
mortality in critically ill patients [38,39]. For this reason, 
these two parameters were adjusted in a multivariable 
Cox model. Finally, area under ROC curve for BMI was 
less than 0.7 in our analysis, suggesting that BMI is not a 
powerful predictor of mortality. Our study had relatively 
small sample size and thus further large-scale investiga-
tions are needed to verify BMI as a useful predictor of 
mortality of AKI patients with CRRT.
In conclusion, this study showed that high BMI is as-
sociated with survival benefit in AKI patients undergoing 
CRRT. Although the causality is uncertain, our findings 
suggest that obesity can function as an energy reservoir 
in this continuously energy-depleting condition.
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